Reaction
Hypersexuality reporting signals
As of the last recalculation, Hypersexuality appears in 1,811 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is RASAGILINE MESYLATE (PRR 130.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rasagiline Mesylate | 118 | 130.3 | 131.7 |
| Pramipexole | 115 | 92.0 | 92.7 |
| Aripiprazole Oral | 219 | 69.1 | 69.5 |
| Aripiprazole Orally Disintegrating | 219 | 69.1 | 69.5 |
| Ropinirole | 87 | 68.4 | 68.8 |
| Aripiprazole | 456 | 56.9 | 57.1 |
| Levodopa | 46 | 44.9 | 45.0 |
| Rotigotine | 46 | 37.5 | 37.6 |
| Carbidopa And Levodopa | 131 | 34.1 | 34.2 |
| Amantadine | 39 | 29.6 | 29.7 |
| Cariprazine | 20 | 25.0 | 25.0 |
| Brexpiprazole | 25 | 17.5 | 17.6 |
| Lurasidone Hydrochloride | 24 | 13.3 | 13.4 |
| Donepezil Hydrochloride | 41 | 13.1 | 13.1 |
| Lithium | 27 | 12.5 | 12.5 |
| Lithium Bromatum | 27 | 12.5 | 12.5 |
| Lithium Carbonate | 18 | 12.3 | 12.3 |
| Fexofenadine | 17 | 11.9 | 11.9 |
| Rivastigmine | 19 | 11.7 | 11.7 |
| Fluoxetine | 60 | 10.7 | 10.7 |
| Paroxetine Hydrochloride Hemihydrate | 26 | 9.1 | 9.1 |
| Haloperidol | 19 | 9.1 | 9.1 |
| Olanzapine | 81 | 9.0 | 9.0 |
| Brivaracetam | 7 | 9.0 | 9.0 |
| Haloperidol Lactate | 19 | 8.9 | 8.9 |
| Paroxetine | 26 | 8.9 | 8.9 |
| Bupropion | 33 | 8.7 | 8.7 |
| Risperidone | 95 | 8.6 | 8.6 |
| Divalproex Sodium | 33 | 8.3 | 8.3 |
| Asenapine Maleate | 6 | 8.0 | 8.0 |
| Lisdexamfetamine Dimesylate | 22 | 7.7 | 7.7 |
| Oxazepam | 12 | 6.5 | 6.5 |
| Vortioxetine | 7 | 4.7 | 4.7 |
| Remdesivir | 5 | 4.3 | 4.3 |
| Pimavanserin Tartrate | 17 | 3.6 | 3.6 |
| Paliperidone | 7 | 3.5 | 3.5 |
| Paliperidone Palmitate | 8 | 2.9 | 2.9 |
| Droxidopa | 3 | 1.6 | 1.6 |
| Valbenazine | 3 | 1.4 | 1.4 |